Tetracosactide

Revision as of 19:56, 27 September 2011 by WikiBot (talk | contribs) (Protected "Tetracosactide": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for Tetracosactide

Articles

Most recent articles on Tetracosactide

Most cited articles on Tetracosactide

Review articles on Tetracosactide

Articles on Tetracosactide in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Tetracosactide

Images of Tetracosactide

Photos of Tetracosactide

Podcasts & MP3s on Tetracosactide

Videos on Tetracosactide

Evidence Based Medicine

Cochrane Collaboration on Tetracosactide

Bandolier on Tetracosactide

TRIP on Tetracosactide

Clinical Trials

Ongoing Trials on Tetracosactide at Clinical Trials.gov

Trial results on Tetracosactide

Clinical Trials on Tetracosactide at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Tetracosactide

NICE Guidance on Tetracosactide

NHS PRODIGY Guidance

FDA on Tetracosactide

CDC on Tetracosactide

Books

Books on Tetracosactide

News

Tetracosactide in the news

Be alerted to news on Tetracosactide

News trends on Tetracosactide

Commentary

Blogs on Tetracosactide

Definitions

Definitions of Tetracosactide

Patient Resources / Community

Patient resources on Tetracosactide

Discussion groups on Tetracosactide

Patient Handouts on Tetracosactide

Directions to Hospitals Treating Tetracosactide

Risk calculators and risk factors for Tetracosactide

Healthcare Provider Resources

Symptoms of Tetracosactide

Causes & Risk Factors for Tetracosactide

Diagnostic studies for Tetracosactide

Treatment of Tetracosactide

Continuing Medical Education (CME)

CME Programs on Tetracosactide

International

Tetracosactide en Espanol

Tetracosactide en Francais

Business

Tetracosactide in the Marketplace

Patents on Tetracosactide

Experimental / Informatics

List of terms related to Tetracosactide

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Tetracosactide is a synthetic analogue of the naturally-occurring hormone, adrenocorticotrophic hormone (ACTH). In the normal situation, ACTH is released from the pituitary gland in the brain. It acts on the adrenal glands to stimulate the production of steroid hormones (glucocorticoids and mineralocorticoids). If the adrenal glands are healthy, a single injection of tetracosactide results in a rise in blood cortisol (hydrocortisone) concentrations in 30 minutes. If the adrenal glands appear not to be working then tetracosactide injection can be given to check whether the problem is due to diseased or damaged adrenals or due to lack of pituitary ACTH.

This medication is used for diagnostic purposes only. It suitable for treatment of adrenal insufficiency of central origin.

It is marketed under the brand name Synacthen.

As well as its legitimate medical applications, it has been widely reported that Synacthen has also been used as an illegal performance enhancing drug by professional cyclists. Template:SIB Template:Pituitary and hypothalamic hormones and analogues


Template:WikiDoc Sources